In the BioHarmony Drug Report Database
Vasopressin
Vasopressin, Vasostrict (vasopressin) is a protein pharmaceutical. Vasopressin was first approved as Vasopressin on 2014-04-17. Vasostrict’s patent is valid until 2035-01-30 (FDA).
Trade Name
|
Vasopressin, Vasostrict |
|---|---|
Common Name
|
vasopressin |
ChEMBL ID
|
CHEMBL373742 |
Indication
|
|
Drug Class
|
Vasoconstrictors (vasopressin derivatives) |
Image (chem structure or protein)